Iran Daru (XTEH:IRDR1) Market Cap : IRR0.00 Mil (As of Jun. 14, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Iran Daru's share price for the quarter that ended in . 20 was IRR. Iran Daru's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Iran Daru's market cap for the quarter that ended in . 20 was IRR Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Iran Daru's Enterprise Value for Today is IRR0.00 Mil.

Iran Daru Market Cap Historical Data

The historical data trend for Iran Daru's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Market Cap Chart

Iran Daru Annual Data

Trend

Market Cap

Iran Daru Semi-Annual Data

Market Cap

Competitive Comparison of Iran Daru's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Market Cap distribution charts can be found below:

* The bar in red indicates where Iran Daru's Market Cap falls into.

Iran Daru Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Iran Daru's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )	=	Share Price (A: . 20 )	*	Shares Outstanding (EOP) (A: . 20 )
	=	IRR	*
	=	IRR

Iran Daru's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )	=	Share Price (Q: . 20 )	*	Shares Outstanding (EOP) (Q: . 20 )
	=	IRR	*	0
	=	IRR

Iran Daru (XTEH:IRDR1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Iran Daru Market Cap Related Terms

Thank you for viewing the detailed overview of Iran Daru's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines